2020
DOI: 10.1016/j.jtcvs.2019.12.001
|View full text |Cite|
|
Sign up to set email alerts
|

2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter mitral valve intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…Considering the clinical (i.e., age, general clinical status, quality of life, frailty, comorbidities, other valves diseases, surgery impediments) and anatomical (i.e., femoral access status, aortic root morphology, size of aortic annulus, aortic valve morphology, concomitant coronary artery disease, coronary ostia origins, concomitant aortopathy) variables to be assessed in selecting the treatment for aortic stenosis, several HT members from different specialties (clinical cardiologist, cardiac imaging specialist, cardiac anaesthesiologist, and other medical specialists) continue to play a key role in this novel decision-making process. While the composition of the HT for aortic stenosis remains substantially unchanged, for the treatment of MR it becomes crucial to include the active participation of heart failure and mitral imaging specialists 4 . Indeed, evidence derived from randomised trials has shown that for functional MR the MitraClip device offers additional clinical benefits to optimal medical therapy in selected symptomatic patients with the strict echocardiographic criteria adopted in the COAPT trial 2 .…”
Section: Division Of Cardiology Policlinico Hospital University Of Catania Catania Italymentioning
confidence: 99%
See 2 more Smart Citations
“…Considering the clinical (i.e., age, general clinical status, quality of life, frailty, comorbidities, other valves diseases, surgery impediments) and anatomical (i.e., femoral access status, aortic root morphology, size of aortic annulus, aortic valve morphology, concomitant coronary artery disease, coronary ostia origins, concomitant aortopathy) variables to be assessed in selecting the treatment for aortic stenosis, several HT members from different specialties (clinical cardiologist, cardiac imaging specialist, cardiac anaesthesiologist, and other medical specialists) continue to play a key role in this novel decision-making process. While the composition of the HT for aortic stenosis remains substantially unchanged, for the treatment of MR it becomes crucial to include the active participation of heart failure and mitral imaging specialists 4 . Indeed, evidence derived from randomised trials has shown that for functional MR the MitraClip device offers additional clinical benefits to optimal medical therapy in selected symptomatic patients with the strict echocardiographic criteria adopted in the COAPT trial 2 .…”
Section: Division Of Cardiology Policlinico Hospital University Of Catania Catania Italymentioning
confidence: 99%
“…Thus, the right clinical patient selection for MitraClip implantation is essential for the effectiveness of this treatment. Regarding decision making for MR treatment, assessment of surgical risk by the HT remains the basis 4 . Thus, with some adaptation, the multidisciplinary approach guided by the surgeon and the interventional cardiologist coordinating different partnerships remains the essential mainstay of any successful catheter-based VHD therapy implementation.…”
Section: Division Of Cardiology Policlinico Hospital University Of Catania Catania Italymentioning
confidence: 99%
See 1 more Smart Citation